Report on the Thirteenth Aberdeen Spring Symposium on Respiratory Medicine: Where are we now and Where Will we be in Ten Years’ Time? *

Abstract

Get full access to this article

View all access options for this article.

References

Smith

. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 304(7):493–501.

British Thoracic Society: guidelines on management of community acquired pneumonia. Br J Hosp Med 1993; 49(5):346–50.

American Thoracic Society: guidelines for initial management of community acquired pneumonia. American Review of Respiratory Disease 1993; 148:1418–26.

Woodhead

. Community-acquired pneumonia guidelines - an international comparison. Chest 1998; 113:1835–75.

Bortless

. Infectious Disease Society of America guidelines. Clin Infect Dis 1998; 26:811–38.

Fine

. A prediction rule to identify low-risk patients with community acquired pneumonia. N Engl J Med 1997; 336(4):243–50.

Omerod

. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1999; 45:403–8.

Beardsman

. Pulmonary function in infants with cystic fibrosis: effect of antibiotic treatment. Arch Dis Child August 1994; 71(2):133–7.

Muktopodhyay

. Nebulised antipserudomona antibiotic therapy in cystic fibrosis: a meta analysis of benefits and risks. Thorax 1996; 51:364–8.

10.

Burr

. Changes in asthma prevalence. Two studies 15 years apart. Arch Dis Child October 1989. 64(10):1452–6.

11.

Peat

. Changing prevalence of asthma in Australian schoolchildren. BMJ June 18. 1994; 308(6944):1591–6.

12.

British Thoracic Society: guidelines on asthma management 1995 review and position statement. Thorax 1997; 52(suppl 1):S1–21.

13.

Greening

. Adding Salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344(8917):219–24.

14.

Paumels

. European Respiratory Society study on chronic obstructive pulmonary disease (Euroscop). Eur Respir J 1992; 5:1254–61.

15.

Burge

. Inhaled steroids in chronic obstructive pulmonary disease in Europe. The ISOLDE trial; protocol and progress. Am J Respir Crit Care Med 1994; 5:1254–61.

16.

Gorecka

. Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997; 52(8):667–8.

17.

Decramer

. Muscle weakness is related to utilisation of health care resources in COPD patients. Eur Respir J 1997; 10(2):417–23.

18.

Smoking cessation guidelines. Thorax 1998; 53(suppl 5, Part1):53–7.

19.

Ferrg and Burchette. Efficacy of bupropion for smoking cessation in non-depressed smokers. J Addict Dis 1994; 13:249.

20.

Hurt

. A comparison of sustained release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337:1195–202.

21.

Richmond

. Physicians can make a difference with smokers: evidence based clinical approaches. International Journal of Tuberculosis and Lung Disease 1999; 3(2):100–12.